| Cerner Primary Mnemonic: | ADmark Alzheimer Eval,CSF |
| PDM | 2159034 |
| Informatics - Workgroup | Chemistry |
| Synonyms * | TAUCSF |
| Display Name * | CSF, ADmark Phospho-Tau/Total-Tau/A Beta42, Analysis and Interpretation (Symptomatic) |
| Specimen Sources (combined Order Entry and Specimen Navigator) * |
|
| Specimen Types (combined Order Entry and Specimen Navigator) * |
CSF
|
| Body Fluids (types sent through AOEs) |
|
| Specimen Navigator Specimen Types |
|
| Specimen Navigator Specimen Sources |
|
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | Admark® Alzheimer's Evaluation, CSF (FDA Cleared) - Elecsys Beta Amyloid (1 42) CSF II, Phospho-Tau (181P) CSF and Elecsys Total Tau CSF are in vitro electrochemiluminescence immunoassays for the measurement of the Beta Amyloid (1 42) (Abeta42), PTau (181P) and Total Tau (tTau) protein concentration in cerebrospinal fluid (CSF) from adult patients aged 55 years and older being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment to generate a tTau/Abeta42 and pTau-181/Abeta42 ratios and values. A negative result, defined as tTau/Abeta42 and Phospho-Tau (181P) ratio values below cutoff or an Abeta42 value above the measuring range, are consistent with a negative amyloid positron emission tomography (PET) scan result. A negative result reduces the likelihood that a patient?s cognitive impairment is due to AD. A positive result, defined as tTau/Abeta42 and pTau181/Abeta42 ratio value above cutoff, is consistent with a positive amyloid PET scan result. A positive result does not establish a diagnosis of AD or other cognitive disorder. The tTau/Abeta42 and pTau181/Abeta42 ratio results are used as an adjunct to other clinical diagnostic evaluations. |
| IP Orderable (inpatient) | Yes |
| OP Orderable (outpatient) | Yes |
AOEs *
|
| AP AOEs | |
| Special History | No |
| Build Comments | |
| Filter * | |
| Cerner Site Restrict | AML/Quest Labs |
Cerner Results
| Result Desc |
Result display |
Result PDM |
| ADmark Phospho-Tau/Total-TA |
TAUCSF |
2159034A |
| tTau/Abeta42 Interp |
TAUCSF6 |
2159034G |
| Summary Interpretation |
TAUCSF1 |
2159034B |
| Comments |
TAUCSF9 |
2159034J |
| pTau181,CSF |
TAUCSF4 |
2159034E |
| Beta-Amyloid (1-42),CSF |
TAUCSF2 |
2159034C |
| tTau,CSF |
TAUCSF3 |
2159034D |
| pTau181/Abeta42 Ratio |
TAUCSF7 |
2159034H |
| pTau181/Abeta42 Interp |
TAUCSF8 |
2159034I |
| tTau/Abeta42 Ratio |
TAUCSF5 |
2159034F |
|
| PROCEDURE ID |
114454 |
| PDM |
2159034 |
| ORDER DISPLAY NAME |
CSF, ADmark Phospho-Tau/Total-Tau/A Beta42, Analysis and Interpretation (Symptomatic) |
| PROCEDURE NAME |
CSF, ADMARK PHOSPHO-TAU/TOTAL-TAU/A BETA42,ANALYSIS AND INTERPRETATION (SYMPTOMATIC) |
| PROCEDURE MASTER NUMBER |
LAB11024 |
| SHORT PROCEDURE NAME |
CSF, ADMARK PHOSPHO-TAU/TOTAL-TAU/A BETA42,ANALYSIS AND INTERPRETATION (SYM |
| CATEGORY CODE |
7.0 |
| CATEGORY CODE RECORD NAME |
LAB BODY FLUIDS AND STOOLS ORDERABLES |
| SYNONYMS |
TAUCSF |
| CLINICALLY ACTIVE |
Yes |
| ORDERABLE |
Yes |
| PERFORMABLE |
Yes |
| FILTER GENOMICS |
|
| REFERENCE LINK URL |
https://labs.northwell.edu/epic/test/114454 |
| ORDERING INSTRUCTIONS |
|
| DEFAULT SPECIMEN TYPE |
Cerebrospinal Fluid |
| SPECIMEN TYPE PICK LIST |
Cerebrospinal Fluid |
| SPECIMEN TYPE LIST |
Cerebrospinal Fluid |
| OP SPECIMEN TYPE LIST |
|
| SPECIMEN SOURCE PICK LIST |
CSF Reservoir
Lumbar Puncture
VP Shunt Aspirate |
| SPECIMEN SOURCE DEFAULT - MALE |
Lumbar Puncture |
| SPECIMEN SOURCE DEFAULT - FEMALE |
Lumbar Puncture |
| SPECIMEN SOURCE LIST |
|
| OP SPECIMEN SOURCE LIST |
|
| IP LAB TEST COMPONENTS FOR REPORT |
ADMARKPHOSTA |
| OP LAB TEST COMPONENTS FOR REPORT |
ADMARKPHOSTA |
| ORDER QUESTIONS |
[] |
| ORDER QUESTIONS RECORD NAME |
|
| INPATIENT ORDER QUESTIONS |
[] |
| INPATIENT ORDER QUESTIONS RECORD NAME |
|
| ORDER SPECIFIC QUESTION OVERRIDE |
|
| INPATIENT QUESTION OVERRIDE |
|
| LOCATION RESTRICT LIST IP |
|
| LOCATION RESTRICT LIST IP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDE IP |
|
| LOCATION RESTRICT LIST OP |
|
| LOCATION RESTRICT LIST OP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDES OP |
|
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME |
|
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME |
|
| EDP IP SPECIMEN SOURCE |
Per Rectum |
| EDP OP SPECIMEN SOURCE |
Per Rectum |
| EDP IP SPECIMEN TYPE |
Stool
Cerebrospinal Fluid |
| EDP OP SPECIMEN TYPE |
Cerebrospinal Fluid
Stool |
| DERIVED EDP IP BUTTONS S |
|
| DERIVED EDP IP BUTTONS T |
Cerebrospinal Fluid |
| DERIVED EDP OP BUTTONS S |
|
| DERIVED EDP OP BUTTONS T |
|
| IP ORDERABLE |
1 |
| OP ORDERABLE |
1 |
| STANDARD LAB COMPONENTS |
|
| STANDARD LAB COMPONENTS RECORD NAME |
|
| COMPONENT DATA REQUIREMENT |
|
EPIC OP AOEs
|
EPIC IP AOEs
|
EPIC Components (results - crosswalked through Cerner)
| Component ID | Component Name | Base Name | Common Name | External Name | Cerner Result PDM |
|---|
| 3047800879.0 |
ADMARK PHOSPHO-TAU/TOTAL-TA |
ADMARKPHOSTA |
ADMARK PHOSPHO TAU TOTAL TA |
ADmark Phospho-Tau/Total-TA |
2159034A |
| 3046001995.0 |
TTAU ABETA42 INTERP |
TAUCSF6 |
TTAU ABETA42 INTERP |
tTau/Abeta42 Interp |
2159034G |
| 304006987.0 |
SUMMARY INTERPRETATION |
TAUCSF1 |
SUMMARY INTERPRETATION |
Summary Interpretation |
2159034B |
| 3046001899.0 |
COMMENTS(TAU,CSF) |
TAUCSF9 |
COMMENTS(TAU,CSF) |
Comments (Tau,CSF) |
2159034J |
| 3046001997.0 |
PTAU181 CSF |
TAUCSF5 |
PTAU181 CSF |
pTau181,CSF |
2159034E |
| 3046006988.0 |
BETA-AMYLOID (1-42) CSF |
TAUCSF2 |
BETA-AMYLOID (1-42) CSF |
Beta-Amyloid (1-42),CSF |
2159034C |
| 3046001999.0 |
TTAU,CSF |
TAUCSF3 |
TTAU,CSF |
tTau,CSF |
2159034D |
| 3046001994.0 |
PTAU181 ABETA 42 RATIO |
TAUCSF7 |
PTAU181 ABETA 42 RATIO |
pTau181/Abeta42 Ratio |
2159034H |
| 30488000695.0 |
PTAU181 ABETA42 INTERP |
TAUCSF8 |
PTAU181 ABETA42 INTERP |
pTau181/Abeta42 Interp |
2159034I |
| 3046001996.0 |
TTAU ABETA42 RATIO |
TAUCSF5 |
TTAU ABETA42 RATIO |
tTau/Abeta42 Ratio |
2159034F |
|
